Concepedia

Jonathan Slawik

JS

Statistics

Publications

5

Citations

187

H-Index

5

Active since

2019

Affiliations

Saarland University(Current)

Universitätsklinikum des Saarlandes

Boehringer Ingelheim (Germany)

Heidelberg University

German Centre for Cardiovascular Research

Jonathan Slawik is an author at Saarland University specializing in cardiovascular pharmacology, patient safety, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2019–2023

5

Publications

5

Efficacy of Empagliflozin on Heart Failure and Renal Outcomes in Patients with Atrial Fibrillation: Data from the EMPA-REG OUTCOME Trial

Michael Böhm, Jonathan Slawik, Martina Brueckmann et al. · European Journal of Heart Failure · 2019 · 102 citations · Full text

Irregular Pacing of Ventricular Cardiomyocytes Induces Pro-Fibrotic Signalling Involving Paracrine Effects of Transforming Growth Factor Beta and Connective Tissue Growth Factor

Jonathan Slawik, Lucas Adrian, Mathias Hohl et al. · European Journal of Heart Failure · 2019 · 27 citations · Full text

Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial

Michael Böhm, Javed Butler, Felix Mahfoud et al. · European Journal of Heart Failure · 2022 · 23 citations · Full text

Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)

Dominic Millenaar, Helmut Schumacher, Martina Brueckmann et al. · The American Journal of Cardiology · 2021 · 21 citations

, , +11

Time to Benefit of Heart Rate Reduction with Ivabradine in Patients with Heart Failure and Reduced Ejection Fraction

Michael Böhm, Amr Abdin, Jonathan Slawik et al. · European Journal of Heart Failure · 2023 · 14 citations · Full text

1–5 of 5